Business Wire

Akselos: Innogy Ventures and Shell Ventures Back Predictive Digital Twin Pioneer with $10 Million Investment

Del

Predictive digital twin pioneer, Akselos, today announces the completion of a $10 million financing round led by innogy Ventures, with Shell Ventures as Co-Investor.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180927005503/en/

Akselos Windturbine and Sensor (Graphic: Business Wire)

Akselos Windturbine and Sensor (Graphic: Business Wire)

The new round of financing will be used to help increase the sustainability of critical assets in the energy sector, by empowering predictive maintenance with structural analysis software, big data analytics and machine learning.

Thomas Leurent, Akselos co-founder and CEO, said: “Today’s announcement underlines the value we will bring to the energy sector and is a huge vote of confidence from two of the world’s most progressive and innovative energy companies. Our technology will not only help maximise efficiency and returns in the oil and gas industry in an increasingly competitive market, but it also has a crucial role to play in accelerating the energy transition. To tackle the many challenges humanity is facing, we need to think beyond incremental innovation and move towards next generation extreme engineering - that’s what Akselos is all about.

“We look forward to working closely with both innogy and Shell and taking advantage of the unrivalled expertise available to us as we continue to pursue our vision and develop our technology.”

Akselos, spun out from MIT, brings emerging digital tech to the market through an exclusive license with MIT. The technology, over 15 years in the making, was further developed at the Swiss Federal Institute of Technology. The technology simulates exact virtual replicas – or digital twins – of large mechanical assets, using data to create accurate living, learning and predictive twins. It’s the first technology of its kind to be compatible with the IoT and digital solutions such as sensors, big data analytics and machine learning.

The solution, which is 1,000 faster and more accurate than the industry standard when modelling large scale assets, will offer operators real-time access to the condition of the asset from anywhere and at any time, and allow a move towards predictive maintenance.

Felix Krause, Investment Partner for innogy Ventures said: “Akselos has a fantastic, highly skilled team with extraordinary market understanding. Their unrivalled expertise in simulation technology has led them to commercialise something that has overcome the limitations of the current industry solution.

“We are very happy to be part of the Akselos story at such an exciting time for the company. Having successfully developed ground-breaking technology and having built an impressive customer base, Akselos is now in a position to focus on growth and continue working towards digital transformation in the energy sector and beyond.”

Peter van Giessel, Investment Director for Shell Ventures said: “Akselos allows us to better monitor the integrity of our most complex assets – be it production vessels or wind turbines. With this technology, engineers can now run analysis almost at the speed of thought. When integrated with real life sensors on the assets, the technology creates a responsive system, enabling cost reduction and enhanced safety.

“We are proud to support the brilliant work of the Akselos team and look forward to seeing this being used throughout our operations.”

In addition to its work with the energy industry, Akselos is currently involved in a number of high-level R&D projects with world-class technology institutes to accelerate the energy transition and space exploration.

http://www.akselos.com/

https://www.innogy.ventures/

https://www.shell.com/energy-and-innovation/innovating-together/shell-ventures.htm

Contact information

Akselos
Lindsay Jepp
ljepp@webershandwick.com
+44 1224 806 600
+44 7580 971 400

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 17:37Pressemelding

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 13:10Pressemelding

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 12:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 11:54Pressemelding

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 11:00Pressemelding

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Tradeshift Announces Q3 2018 Results19.10.2018 11:00Pressemelding

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between